Term
| Medication Therapy Management (as defined by CMS) |
|
Definition
| A program that ensures optimum therapeutic outcomes for targeted beneficiaries through improved medication use. |
|
|
Term
| Medication Therapy Review or Comprehensive Medication Review |
|
Definition
| Systematic process of collecting patient information, assessing medication therapies, developing a prioritized list of drug-related problems, creating a plan to solve drug-related problems. |
|
|
Term
| Personal medication record (PMR) |
|
Definition
| Personal medication record of all medications (including OTCs, supplements and herbals) intended for use by the patient. |
|
|
Term
| Medication-Related Action Plan (MAP) |
|
Definition
| A ‘patient-centric’ document to communicate self-management instructions |
|
|
Term
|
Definition
| redness of the skin/extremities as a result of inflammation |
|
|
Term
|
Definition
| a vague feeling of discomfort, fatigue, or uneasiness, typically as a result of infection |
|
|
Term
|
Definition
| Methicillin-susceptible Staphylococcus aureus |
|
|
Term
|
Definition
| Methicillin– resistant Staphylococcus aureus |
|
|
Term
|
Definition
| Vancomycin resistant enterococci |
|
|
Term
|
Definition
| Of, relating to, or caused by multiple organisms |
|
|
Term
|
Definition
| Establishment of the pathogen without symptomatic infection |
|
|
Term
|
Definition
| Infected by contact or association |
|
|
Term
|
Definition
| Study of structure or form |
|
|
Term
|
Definition
| Interaction with a microbe causing damage to the host, and the associated damage or altered physiology results in clinical signs and symptoms of disease |
|
|
Term
|
Definition
| Organisms found in and on specific areas of the body that do not typically result in infectious processes |
|
|
Term
|
Definition
| Organisms capable of damaging host tissues and eliciting host responses and symptoms consistent with an infectious process |
|
|
Term
|
Definition
| Increase in the total number of white blood cells due to any cause |
|
|
Term
| Left shift (aka shifted to the left, left shifted) |
|
Definition
| Increase in the number of immature leukocytes in peripheral blood |
|
|
Term
|
Definition
| Able to overcome bodily defensive mechanisms |
|
|
Term
|
Definition
| Fever of 100.3 for 1 hour or 101 F for anything length of time with an ANC of less than 500 |
|
|
Term
|
Definition
| Fever of 100.3 for 1 hour or 101 F for anything length of time with an ANC of less than 1500 |
|
|
Term
|
Definition
| Absolute neutrophil count less than 1500 cells/mm3 |
|
|
Term
|
Definition
| Absolute neutrophil count less than 500 cells/mm3 |
|
|
Term
|
Definition
| inflammation of the cecum and large intestine associated with fever and abdominal pain in a neutropenic patient |
|
|
Term
|
Definition
| inflammation of the mucosal membranes of the GI tract, ulceration and pain are common |
|
|
Term
|
Definition
| Infection with, or disease caused by, Candida, especially C. albicans. This disease usually results from debilitation (as in immunosuppression and especially AIDS), physiologic change, prolonged administration of antibiotics, and iatrogenic and barrier breakage |
|
|
Term
|
Definition
| candidiasis of the tissues of the mouth. The condition is characterized by the appearance of creamy white patches of exudate on an inflamed tongue or buccal mucosa |
|
|
Term
|
Definition
| absolute neutrophil count, which equals to the Total WBC count multiplied by the total percentage of neutrophils (segs plus bands) |
|
|
Term
|
Definition
| Having an immune system that has been impaired by disease or treatment |
|
|
Term
|
Definition
| a disease caused by species of Aspergillus, marked by inflammatory granulomatous lesions in the skin, ear, orbit, nasal sinuses, lungs, bones, and meninges |
|
|
Term
|
Definition
| Pronounced reduction in the number of erythrocytes, all types of leukocytes, and the blood platelets in the circulating blood |
|
|
Term
| Systemic Inflammatory Response Syndrome (SIRS) |
|
Definition
defined as ³ 2 of the following:
• temperature > 38 or < 36 C°
• heart rate > 90 bpm
• respiratory rate > 20 bpm or PaCO2 < 32 mmHg
• white blood count > 12,000/mm3, < 4,000/mm3 or > 10% bands |
|
|
Term
|
Definition
| SIRS related to infection |
|
|
Term
|
Definition
| sepsis associated with organ dysfunction and hypoperfusion |
|
|
Term
|
Definition
| sepsis with hypotension and perfusion abnormalities despite adequate fluid resuscitation |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| the ability to expire CO2 |
|
|
Term
|
Definition
| the ability to inspire and transfer O2 to the circulation |
|
|
Term
|
Definition
| amount of blood pumped per time = heart rate x volume pumped |
|
|
Term
|
Definition
| systemic vascular resistance, pressure gradient exerted across the entire body’s vessels |
|
|
Term
|
Definition
| The process of introducing an antigen into the body to induce protection against the infectious agent without causing disease |
|
|
Term
|
Definition
| A substance that induces an immune response |
|
|
Term
|
Definition
| The response that is measured as evidence of successful vaccination |
|
|
Term
|
Definition
| The transfer of antibody produced by one human or other animal to another; provides temporary protection; most common for is that which an infant receives from its mother |
|
|
Term
|
Definition
| Stimulation of the immune system to product antigen-specific humoral (antibody) and cellular immunity; usually lasts for many years, often for a lifetime; two ways to acquire active immunity are to have the natural disease and by vaccination |
|
|
